Clinical Trial Update: SGLTi, Hepatic Glucose Production and Ketogenesis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating an SGLT inhibitor's effects on hepatic glucose production and ketogenesis in Type 2 diabetes patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type 2 Diabetes | Phase 1 | Status: RECRUITING